Frances W. Grimstad, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transsexualism | 8 | 2023 | 178 | 3.990 |
Why?
|
| Sex Reassignment Procedures | 6 | 2021 | 50 | 3.660 |
Why?
|
| Testosterone | 11 | 2024 | 2420 | 2.970 |
Why?
|
| Metrorrhagia | 3 | 2024 | 18 | 2.470 |
Why?
|
| Disorders of Sex Development | 3 | 2023 | 122 | 2.340 |
Why?
|
| Contraception | 4 | 2022 | 359 | 1.380 |
Why?
|
| Genitalia, Female | 2 | 2023 | 146 | 1.330 |
Why?
|
| Gender Identity | 9 | 2023 | 688 | 1.310 |
Why?
|
| Clitoris | 2 | 2021 | 33 | 1.300 |
Why?
|
| Endometrium | 3 | 2018 | 424 | 1.120 |
Why?
|
| Gynecology | 2 | 2021 | 513 | 1.050 |
Why?
|
| Endometriosis | 3 | 2020 | 839 | 1.040 |
Why?
|
| Ovary | 3 | 2020 | 981 | 0.990 |
Why?
|
| Pelvic Pain | 5 | 2023 | 274 | 0.970 |
Why?
|
| 46, XX Disorders of Sex Development | 1 | 2023 | 31 | 0.930 |
Why?
|
| Colpotomy | 2 | 2022 | 14 | 0.910 |
Why?
|
| Menstruation Disturbances | 2 | 2021 | 148 | 0.820 |
Why?
|
| Hyperandrogenism | 1 | 2021 | 38 | 0.800 |
Why?
|
| Oxandrolone | 1 | 2021 | 23 | 0.790 |
Why?
|
| Sex Reassignment Surgery | 2 | 2022 | 130 | 0.790 |
Why?
|
| Congenital Abnormalities | 2 | 2023 | 707 | 0.770 |
Why?
|
| Gynecological Examination | 1 | 2020 | 33 | 0.750 |
Why?
|
| Intrauterine Devices | 1 | 2022 | 122 | 0.740 |
Why?
|
| Androgens | 4 | 2021 | 1281 | 0.710 |
Why?
|
| Hymen | 1 | 2019 | 16 | 0.690 |
Why?
|
| Penis | 1 | 2020 | 216 | 0.690 |
Why?
|
| Women's Rights | 1 | 2019 | 69 | 0.680 |
Why?
|
| Dysmenorrhea | 1 | 2020 | 86 | 0.680 |
Why?
|
| Vagina | 2 | 2020 | 825 | 0.650 |
Why?
|
| Endometrial Hyperplasia | 1 | 2018 | 97 | 0.620 |
Why?
|
| Family Planning Services | 1 | 2020 | 263 | 0.600 |
Why?
|
| Prolactin | 1 | 2018 | 669 | 0.560 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2018 | 744 | 0.540 |
Why?
|
| Estradiol | 3 | 2023 | 2020 | 0.540 |
Why?
|
| Abortion, Habitual | 1 | 2016 | 70 | 0.540 |
Why?
|
| Disclosure | 1 | 2022 | 736 | 0.540 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2016 | 160 | 0.530 |
Why?
|
| Luteinizing Hormone | 1 | 2018 | 869 | 0.530 |
Why?
|
| Birth Rate | 1 | 2016 | 170 | 0.520 |
Why?
|
| Body Height | 2 | 2022 | 1577 | 0.520 |
Why?
|
| Gonadal Dysgenesis | 1 | 2014 | 30 | 0.510 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2014 | 177 | 0.490 |
Why?
|
| Abdominal Pain | 1 | 2020 | 1063 | 0.460 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2015 | 188 | 0.460 |
Why?
|
| Pregnancy Rate | 1 | 2016 | 643 | 0.460 |
Why?
|
| Pituitary Diseases | 1 | 2014 | 141 | 0.460 |
Why?
|
| Female | 42 | 2024 | 380194 | 0.420 |
Why?
|
| Fertilization in Vitro | 2 | 2018 | 1284 | 0.410 |
Why?
|
| Adolescent | 17 | 2024 | 85781 | 0.410 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2015 | 360 | 0.400 |
Why?
|
| Amenorrhea | 1 | 2014 | 485 | 0.380 |
Why?
|
| HLA Antigens | 1 | 2016 | 1381 | 0.370 |
Why?
|
| Women's Health | 1 | 2019 | 2034 | 0.360 |
Why?
|
| Young Adult | 14 | 2024 | 56430 | 0.350 |
Why?
|
| Infertility | 1 | 2016 | 655 | 0.350 |
Why?
|
| Cicatrix | 1 | 2015 | 764 | 0.340 |
Why?
|
| Humans | 49 | 2024 | 744343 | 0.340 |
Why?
|
| Diagnostic Imaging | 2 | 2020 | 3507 | 0.340 |
Why?
|
| Delivery of Health Care | 3 | 2021 | 5319 | 0.340 |
Why?
|
| Counseling | 3 | 2022 | 1523 | 0.330 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 3396 | 0.310 |
Why?
|
| Retrospective Studies | 13 | 2024 | 77449 | 0.310 |
Why?
|
| Killer Cells, Natural | 1 | 2016 | 2133 | 0.290 |
Why?
|
| Kidney Transplantation | 1 | 2021 | 4251 | 0.270 |
Why?
|
| Pediatrics | 1 | 2020 | 3475 | 0.260 |
Why?
|
| Quality Improvement | 1 | 2020 | 3749 | 0.260 |
Why?
|
| Hysterectomy | 2 | 2023 | 927 | 0.260 |
Why?
|
| Infant, Newborn | 6 | 2022 | 25625 | 0.250 |
Why?
|
| Radiology Department, Hospital | 2 | 2019 | 412 | 0.250 |
Why?
|
| Adult | 18 | 2024 | 214055 | 0.250 |
Why?
|
| Telemedicine | 1 | 2021 | 2872 | 0.240 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 3647 | 0.240 |
Why?
|
| Male | 23 | 2023 | 350118 | 0.230 |
Why?
|
| DNA Methylation | 1 | 2017 | 4286 | 0.230 |
Why?
|
| Mullerian Ducts | 1 | 2023 | 198 | 0.220 |
Why?
|
| Genitalia | 1 | 2023 | 112 | 0.220 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.210 |
Why?
|
| Hirsutism | 1 | 2021 | 69 | 0.200 |
Why?
|
| Sexual Development | 1 | 2021 | 34 | 0.200 |
Why?
|
| Gonads | 1 | 2021 | 109 | 0.200 |
Why?
|
| Vaginal Fistula | 1 | 2020 | 18 | 0.190 |
Why?
|
| Danazol | 1 | 2020 | 42 | 0.190 |
Why?
|
| Puberty | 2 | 2022 | 490 | 0.190 |
Why?
|
| Ovariectomy | 1 | 2023 | 661 | 0.190 |
Why?
|
| Uterine Cervical Diseases | 1 | 2020 | 77 | 0.180 |
Why?
|
| Contraceptive Agents | 1 | 2022 | 151 | 0.180 |
Why?
|
| Child | 8 | 2022 | 77709 | 0.180 |
Why?
|
| Pandemics | 1 | 2020 | 8388 | 0.180 |
Why?
|
| Contraceptive Devices | 1 | 2019 | 24 | 0.180 |
Why?
|
| Sterilization, Reproductive | 1 | 2019 | 21 | 0.180 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2020 | 113 | 0.170 |
Why?
|
| Intrauterine Devices, Copper | 1 | 2019 | 32 | 0.170 |
Why?
|
| Patient Advocacy | 1 | 2021 | 353 | 0.170 |
Why?
|
| Urethra | 1 | 2021 | 408 | 0.170 |
Why?
|
| Fistula | 1 | 2020 | 220 | 0.160 |
Why?
|
| Pregnancy, Unplanned | 1 | 2019 | 95 | 0.160 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 10180 | 0.160 |
Why?
|
| Cryopreservation | 1 | 2023 | 670 | 0.160 |
Why?
|
| Sexual Behavior | 3 | 2022 | 2057 | 0.160 |
Why?
|
| Hair | 1 | 2021 | 483 | 0.160 |
Why?
|
| Boston | 2 | 2021 | 9313 | 0.150 |
Why?
|
| Pregnancy | 6 | 2022 | 29144 | 0.150 |
Why?
|
| Decision Making | 2 | 2023 | 3887 | 0.150 |
Why?
|
| Granulosa Cells | 1 | 2018 | 120 | 0.150 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2021 | 280 | 0.150 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2018 | 182 | 0.140 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2020 | 336 | 0.140 |
Why?
|
| Postoperative Complications | 1 | 2019 | 15295 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 7181 | 0.140 |
Why?
|
| Immunogenetics | 1 | 2016 | 67 | 0.140 |
Why?
|
| Prisoners | 1 | 2019 | 297 | 0.140 |
Why?
|
| Ovarian Follicle | 1 | 2018 | 247 | 0.140 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2021 | 3022 | 0.140 |
Why?
|
| Fertility | 1 | 2021 | 781 | 0.140 |
Why?
|
| Medical History Taking | 1 | 2019 | 783 | 0.130 |
Why?
|
| Radiology, Interventional | 1 | 2019 | 460 | 0.130 |
Why?
|
| Prejudice | 1 | 2019 | 570 | 0.120 |
Why?
|
| Physician's Role | 1 | 2021 | 943 | 0.120 |
Why?
|
| Suture Techniques | 1 | 2019 | 798 | 0.120 |
Why?
|
| Cross-Sectional Studies | 4 | 2022 | 25043 | 0.110 |
Why?
|
| Directive Counseling | 1 | 2015 | 166 | 0.110 |
Why?
|
| Violence | 1 | 2019 | 909 | 0.110 |
Why?
|
| Abnormalities, Multiple | 1 | 2020 | 1416 | 0.110 |
Why?
|
| Receptors, Progesterone | 1 | 2017 | 1097 | 0.110 |
Why?
|
| Postoperative Care | 1 | 2019 | 1486 | 0.110 |
Why?
|
| Prevalence | 3 | 2023 | 15226 | 0.100 |
Why?
|
| Terminology as Topic | 1 | 2019 | 1547 | 0.100 |
Why?
|
| Uterus | 1 | 2016 | 711 | 0.100 |
Why?
|
| Menstrual Cycle | 1 | 2015 | 551 | 0.100 |
Why?
|
| Reference Values | 1 | 2018 | 4982 | 0.100 |
Why?
|
| Health Services Needs and Demand | 1 | 2019 | 1411 | 0.090 |
Why?
|
| Quality of Life | 2 | 2022 | 12804 | 0.090 |
Why?
|
| Patient Participation | 1 | 2020 | 1457 | 0.090 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2014 | 370 | 0.090 |
Why?
|
| Estrogens | 1 | 2017 | 1566 | 0.090 |
Why?
|
| Heterosexuality | 2 | 2022 | 276 | 0.090 |
Why?
|
| Venous Thromboembolism | 1 | 2022 | 1671 | 0.090 |
Why?
|
| Bisexuality | 2 | 2022 | 270 | 0.090 |
Why?
|
| Disabled Persons | 1 | 2019 | 1212 | 0.090 |
Why?
|
| Infant | 2 | 2021 | 35136 | 0.090 |
Why?
|
| Self Report | 1 | 2020 | 3558 | 0.090 |
Why?
|
| Treatment Outcome | 3 | 2020 | 63114 | 0.080 |
Why?
|
| Histones | 1 | 2018 | 2599 | 0.080 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 3229 | 0.070 |
Why?
|
| Incidence | 1 | 2024 | 20947 | 0.070 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 3843 | 0.060 |
Why?
|
| Middle Aged | 4 | 2020 | 213383 | 0.060 |
Why?
|
| Kidney | 1 | 2020 | 7186 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 3923 | 0.060 |
Why?
|
| Primary Health Care | 1 | 2020 | 4558 | 0.060 |
Why?
|
| Recurrence | 1 | 2015 | 8340 | 0.060 |
Why?
|
| Pelvic Floor | 1 | 2023 | 138 | 0.050 |
Why?
|
| Cytokines | 1 | 2016 | 7322 | 0.050 |
Why?
|
| Medical Illustration | 1 | 2020 | 133 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2015 | 9146 | 0.040 |
Why?
|
| Pain | 1 | 2015 | 4986 | 0.040 |
Why?
|
| Standard of Care | 1 | 2023 | 564 | 0.040 |
Why?
|
| Physical Therapy Modalities | 1 | 2023 | 550 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2021 | 41006 | 0.040 |
Why?
|
| United States | 3 | 2022 | 69872 | 0.040 |
Why?
|
| Oocyte Retrieval | 1 | 2018 | 161 | 0.040 |
Why?
|
| Hormones | 1 | 2021 | 889 | 0.040 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2021 | 652 | 0.040 |
Why?
|
| Organizational Policy | 1 | 2019 | 429 | 0.030 |
Why?
|
| Inservice Training | 1 | 2019 | 392 | 0.030 |
Why?
|
| Syndrome | 1 | 2020 | 3251 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 39050 | 0.030 |
Why?
|
| Aged | 1 | 2020 | 163280 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 2795 | 0.020 |
Why?
|
| Education, Medical | 1 | 2019 | 1721 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 2291 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 12959 | 0.020 |
Why?
|
| Mass Screening | 1 | 2021 | 5255 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2019 | 3309 | 0.010 |
Why?
|